Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-31 Purchase |
2022-04-04 4:05 pm |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
6,400 | $1.53 | $9,792 | 113,237 (Direct) |
View |
| 2022-03-28 Purchase |
2022-03-29 4:15 pm |
Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director |
35,000 | $1.63 | $57,050 | 35,000 (Direct) |
View |
| 2022-03-25 Purchase |
2022-03-28 7:22 pm |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
5,250 | $1.38 | $7,245 | 81,280 (Direct) |
View |
| 2022-03-23 Purchase |
2022-03-25 5:56 pm |
Lineage Cell Therapeutics Inc. | LCTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner |
930,106 | $1.4167 | $1,317,667 | 69,958,598 (Indirect Direct) |
View |
| 2022-03-24 Purchase |
2022-03-25 4:15 pm |
Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director |
7,000 | $1.4 | $9,800 | 258,555 (Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 5:20 pm |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
539,283 | $2.4502 | $1,321,329 | 551,862 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-11 Tax Withholding |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
12,744 | $1.35 | 220,147 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
31,249 | $0 | 220,147 (Direct) |
View |
| 2023-02-11 Tax Withholding |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary |
2,478 | $1.35 | 21,825 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary |
6,076 | $0 | 21,825 (Direct) |
View |
| 2023-02-11 Tax Withholding |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
5,310 | $1.35 | 46,771 (Direct) |
View |
| 2023-02-11 Exercise |
2023-02-14 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
13,020 | $0 | 46,771 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 4:17 pm |
N/A 2032-11-14 |
Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
Ownership |
2022-07-08 6:25 pm |
N/A 2029-09-01 |
Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller |
0 | $0 | 219,892 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:16 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner |
50,000 | $0 | 229,440 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 4:15 pm |
N/A 2032-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-06-30 Exercise |
2022-06-30 5:57 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
15,450 | $0 | 107,894 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-06-30 5:57 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
5,343 | $1.58 | 107,894 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 4:05 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
5,343 | $1.54 | 113,237 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 4:05 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
15,450 | $0 | 113,237 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 8:45 pm |
N/A 2032-03-10 |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
1,550,000 | $0 | 1,550,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 8:44 pm |
N/A 2032-03-10 |
Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary |
650,000 | $0 | 650,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 8:43 pm |
N/A 2032-03-10 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
450,000 | $0 | 450,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-11 8:42 pm |
N/A 2032-03-10 |
Lineage Cell Therapeutics Inc. | LCTX | Cook Kevin Leon Chief Financial Officer |
650,000 | $0 | 650,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 7:45 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary |
24,303 | $0 | 24,303 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 7:42 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
52,081 | $0 | 52,081 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 7:40 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Cook Kevin Leon Chief Financial Officer |
13,888 | $0 | 13,888 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 7:38 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
124,997 | $0 | 124,997 (Direct) |
View |
Ownership |
2022-02-11 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
0 | $0 | 6,874,242 (Indirect) |
View |
| 2021-12-01 Ownership |
2022-02-11 4:15 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
14,700 | $0 | 6,874,242 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-03 4:25 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
5,343 | $2.45 | 106,930 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-03 4:25 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
15,450 | $0 | 106,930 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A 2030-03-17 |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
510,838 | $0 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
236,899 | $2.11 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
194,250 | $0.6919 | 551,862 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 5:20 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs |
79,689 | $1.14 | 551,862 (Direct) |
View |
| 2021-09-30 Tax Withholding |
2021-10-12 4:27 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
5,343 | $2.52 | 112,273 (Direct) |
View |
| 2021-09-30 Exercise |
2021-10-12 4:27 pm |
N/A N/A |
Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO |
15,450 | $0 | 112,273 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-02 4:20 pm |
N/A 2031-09-01 |
Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary |
695,000 | $0 | 695,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:32 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:29 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:26 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:24 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:24 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner |
50,000 | $0 | 204,160 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-01 6:21 pm |
N/A 2031-07-01 |
Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director |
80,000 | $0 | 80,000 (Direct) |
View |